Which technique lasts longer for an active knee

When a surgeon recommends mosaicplasty rather than microfracture for a knee cartilage defect, the question most athletes ask is a practical one: why not the simpler procedure? For patients with focal osteochondral defects — the kind produced by concentrated, repetitive joint loading rather than the widespread cartilage loss of advanced osteoarthritis — the answer is durability.

The landmark evidence comes from the prospective randomised controlled trial by Gudas and colleagues, cited across major musculoskeletal textbooks as the definitive head-to-head comparison of mosaicplasty versus microfracture in an active athletic cohort. Results favoured mosaicplasty on functional outcomes and return-to-sport rates, with the advantage widening progressively beyond two to three years — the point at which the fibrocartilage produced by microfracture tends to degrade under athletic load. Hyaline cartilage, which mosaicplasty restores, is structurally better suited to withstand the repeated demands of sport.

That trajectory is reflected in clinical practice. A 2021 cartilage surgery reference text notes that the use of microfracture has significantly decreased in the active population as osteochondral autograft transplantation has become the more widely adopted choice for symptomatic focal defects — suggesting practitioner consensus has moved in favour of autograft even as longer-term trial data continue to be disseminated.

Why repair tissue type determines long-term durability

The difference between these two procedures comes down to what fills the defect once the operation is complete.

OATS harvests cylindrical plugs of living cartilage and the underlying bone from a quieter, lower-demand part of the same knee — typically the periphery of the femoral condyle — and press-fits them directly into the prepared lesion. The result is genuine hyaline cartilage restored to the joint surface: the same dense, precisely structured tissue that originally lined the defect, complete with its supporting bone architecture beneath. Think of it as replacing a damaged section of hardwood floor with a matching piece cut from the same board — the grain, the density, and the load-bearing properties align. Because the material is the patient's own tissue, there is no risk of immune rejection and no need for cell culture or a return trip to theatre.

Microfracture takes a fundamentally different route. The surgeon perforates the exposed subchondral bone with small awls, releasing blood and marrow cells that clot over the defect and mature into fibrocartilage — a scar-like repair tissue. In the short term it covers the lesion; under the microscope, however, it lacks the organised collagen architecture of hyaline cartilage, making it mechanically weaker and less able to absorb cyclic impact. For a patient who walks and cycles at a moderate pace, that limitation may remain tolerable. For an athlete absorbing repetitive high-force loading across a career, the structural shortfall becomes clinically consequential.

There is an additional consideration for treatment planning. The awls used in microfracture disrupt the subchondral bone plate — the dense mineralised layer that distributes joint load beneath the cartilage surface. Once compromised, that plate can be harder to address satisfactorily if the fibrocartilage repair eventually fails and a revision procedure becomes necessary. OATS, by transferring plugs that include their own bone component, leaves the subchondral architecture at the repair site intact.

What the ten-year evidence actually shows

The Gudas prospective randomised controlled trial is the evidence the field most consistently returns to when comparing mosaicplasty against microfracture in athletes. Its methodological standing matters: patients with osteochondral knee defects were allocated to one procedure or the other at the outset, with outcomes tracked across both a three-year and a ten-year horizon — a trial design that controls for the selection biases that can confound retrospective series or registry comparisons.

Both timepoints favoured mosaicplasty. Patients in the mosaicplasty group demonstrated superior results on the validated functional outcome instruments used in the trial — including the International Knee Documentation Committee (IKDC) scale and the Lysholm score — and higher rates of return to sport. The more telling finding, however, lay in the pattern across time: rather than converging as both repair tissues matured, the performance gap between groups widened at ten years. Fibrocartilage is structurally prone to progressive wear under load, and the trial's extended follow-up captures that deterioration in practice rather than as a theoretical projection.

For an athlete in their twenties or thirties, a ten-year follow-up still falls comfortably within a likely sporting career. Evidence that a durability advantage compounds rather than diminishes over that period carries real clinical weight when setting expectations at the time of index surgery. A repair that performs adequately at two years but deteriorates by eight or ten creates a downstream problem — and, depending on how far the original microfracture procedure disrupted the underlying subchondral bone plate, the revision options available at that stage may already be more limited than they would have been had a more durable repair been chosen first.

Who is a suitable candidate for OATS

The clearest OATS candidate is an active patient with a focal, symptomatic osteochondral defect on the femoral condyle measuring 1–4 cm² at ICRS grade III or IV, who faces years of sustained high joint demand. That profile describes most competitive and recreational athletes presenting to a cartilage specialist with a lesion of this kind.

Defect size is the practical gatekeeper. Within the 1–4 cm² range, autograft plugs harvested from the low-demand periphery of the same knee can fill the lesion reliably in a single operation. Age and activity level sharpen the decision further: a 28-year-old club rugby player returning to contact sport is precisely the profile the Gudas trial cohort resembled — high load, a long career ahead — and that is where OATS shows its strongest advantage over microfracture.

Once a defect exceeds approximately 4 cm², the donor zone of a single knee cannot supply enough plugs without creating meaningful harvest complications. Above that threshold, fresh osteochondral allograft (OCA) or a cell-based approach such as MACI becomes the more appropriate route.

Microfracture retains a narrow, specific role: for very small defects — broadly under 1–2 cm² — in a non-elite or older patient, or occasionally as a temporising measure, it can provide acceptable short-term relief. It is not an equivalent choice for a competitive athlete with a mid-sized lesion; the ten-year durability data are clear on that distinction.

Donor-site morbidity — discomfort or altered loading at the harvest zone — is a real consideration and should form part of any preoperative discussion. In most patients it proves modest and settles during rehabilitation, though individual anatomy influences harvest feasibility and consultant assessment is required to confirm suitability for each case.

Recovery timeline and return to sport

Recovery after OATS follows a structured, deliberately paced sequence. Protected weight-bearing on crutches for the first six to eight weeks allows the transplanted plugs to integrate into surrounding bone; loading the graft too early risks displacing it before osseointegration is complete. Progressive load introduction, guided range-of-motion work, and sport-specific conditioning phases then extend the full return-to-training window to broadly six to twelve months, depending on defect size, location, and the physical demands of the athlete's sport.

That is longer than the early recovery window after microfracture, which tends to allow return to lower-level activity sooner. The comparison matters: the shorter initial window after microfracture reflects how little structural reconstruction the procedure performs. Where the Gudas cohort is most telling is not at the two-year mark — when microfracture outcomes can still look acceptable — but from around years two to three onward, as fibrocartilage shows the load-related deterioration captured in the trial's longer follow-up. The extended OATS recovery is, in effect, the cost of a more durable repair.

Donor-site rehabilitation adds a layer of planning absent after microfracture. Physiotherapy programmes following OATS address both the graft site and the harvest zone concurrently, and this dual focus can influence the overall schedule.

Precise stratified benchmarks — return-to-sport rates disaggregated by sport type, defect location, or lesion size — are not well established in the comparative literature on these two procedures. The Gudas trial provides the most robust available evidence in an athletic cohort, and clinicians making individualised return-to-sport projections draw primarily on that data alongside their own case experience.

What this means for long-term joint health

The repair choice made at index surgery casts a long shadow. Sanders and colleagues, reporting a mean 16-year follow-up in the American Journal of Sports Medicine in 2017, found high rates of osteoarthritis in patients managed by osteochondral fragment excision rather than surgical restoration — a finding that extends the OATS versus microfracture decision well beyond the return-to-sport conversation covered in earlier sections.

For a patient in their late twenties or early thirties, that choice may directly influence whether a knee replacement becomes necessary two or three decades later. The high-demand athletic profile that makes OATS the stronger short- and medium-term option does so for the same reasons that apply over the long term: restoring hyaline cartilage and subchondral bone architecture, rather than a fibrocartilage fill that degrades under repetitive load, gives the joint a more durable biological foundation.

This is not a guarantee of lifelong preservation. Defect location, overall limb alignment, and individual loading patterns all shape outcomes, and some patients will require further intervention regardless of initial technique. What the evidence does support is that a structurally faithful repair — one that matches the original tissue type as closely as possible — represents the better starting point for a patient whose knee must remain functional across decades of activity.

Microfracture's declining use in the active population reflects this longer view: short-term symptom relief that gives way to fibrocartilage breakdown carries a meaningful downstream cost for younger patients.

Specialist assessment to determine individual suitability — without the need for a GP referral — is available at MSK Doctors.

1. [1] Osteochondritis dissecans. https://en.wikipedia.org/?curid=3762029 https://en.wikipedia.org/?curid=3762029